Zouheir Habbal Mohammad, Bou-Assi Tarek, Zhu Jun, Owen Renius, Chehab Farid F
Department of Pathology and Laboratory Medicine, American University of Beirut, Beirut, Lebanon.
Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America.
PLoS One. 2014 Sep 18;9(9):e106948. doi: 10.1371/journal.pone.0106948. eCollection 2014.
Alkaptonuria is often diagnosed clinically with episodes of dark urine, biochemically by the accumulation of peripheral homogentisic acid and molecularly by the presence of mutations in the homogentisate 1,2-dioxygenase gene (HGD). Alkaptonuria is invariably associated with HGD mutations, which consist of single nucleotide variants and small insertions/deletions. Surprisingly, the presence of deletions beyond a few nucleotides among over 150 reported deleterious mutations has not been described, raising the suspicion that this gene might be protected against the detrimental mechanisms of gene rearrangements. The quest for an HGD mutation in a proband with AKU revealed with a SNP array five large regions of homozygosity (5-16 Mb), one of which includes the HGD gene. A homozygous deletion of 649 bp deletion that encompasses the 72 nucleotides of exon 2 and surrounding DNA sequences in flanking introns of the HGD gene was unveiled in a proband with AKU. The nature of this deletion suggests that this in-frame deletion could generate a protein without exon 2. Thus, we modeled the tertiary structure of the mutant protein structure to determine the effect of exon 2 deletion. While the two β-pleated sheets encoded by exon 2 were missing in the mutant structure, other β-pleated sheets are largely unaffected by the deletion. However, nine novel α-helical coils substituted the eight coils present in the native HGD crystal structure. Thus, this deletion results in a deleterious enzyme, which is consistent with the proband's phenotype. Screening for mutations in the HGD gene, particularly in the Middle East, ought to include this exon 2 deletion in order to determine its frequency and uncover its origin.
黑尿症通常通过临床出现深色尿液发作来诊断,通过外周尿黑酸的积累进行生化诊断,并通过尿黑酸1,2 -双加氧酶基因(HGD)中的突变进行分子诊断。黑尿症总是与HGD突变相关,这些突变包括单核苷酸变异和小的插入/缺失。令人惊讶的是,在超过150个报道的有害突变中,尚未描述超过几个核苷酸的缺失情况,这引发了人们对该基因可能受到基因重排有害机制保护的怀疑。在一名患有黑尿症的先证者中寻找HGD突变时,通过单核苷酸多态性阵列发现了五个大的纯合区域(5 - 16兆碱基),其中一个区域包含HGD基因。在一名患有黑尿症的先证者中发现了一个649碱基对的纯合缺失,该缺失涵盖了HGD基因第2外显子的72个核苷酸以及侧翼内含子中的周围DNA序列。这种缺失的性质表明这种框内缺失可能产生一种没有第2外显子的蛋白质。因此,我们对突变蛋白结构的三级结构进行建模,以确定第2外显子缺失的影响。虽然突变结构中缺少由第2外显子编码的两个β折叠片层,但其他β折叠片层在很大程度上不受缺失的影响。然而,九个新的α螺旋取代了天然HGD晶体结构中存在的八个螺旋。因此,这种缺失导致了一种有害的酶,这与先证者的表型一致。在HGD基因中进行突变筛查时,特别是在中东地区,应该包括这种第2外显子缺失,以确定其频率并揭示其起源。